You are here: Industry Insights > Merck

News List

Merck bags adjuvant okay for Keytruda in melanoma pharmaphorum
December 19, 2018
Checkpoint inhibitors have already revolutionised the treatment of advanced melanoma, and Merck & Co has just claimed approval for even earlier use of its Keytruda product in Europe.
Merck to buy animal health firm Antelliq for $2.4bn pharmaphorum
December 18, 2018
Merck & Co is to buy animal health firm Antelliq Group for $2.4 billion in a bid to bolster this fast-growing business unit.Antelliq, which is majority owned by private investors BC Partners....
WHO worries Merck's Ebola vaccine will run short: report fiercepharma
December 13, 2018
Nearly five months into an Ebola outbreak in the Democratic Republic of Congo, the disease is spreading closer to urban population centers, and that has health officials worried the vaccine stockpile won't meet demand, Stat reports.
Merck’s Ebola vaccine widely used in latest outbreak: WHO official fiercepharma
December 12, 2018
Merck’s Ebola vaccine rVSV-ZEBOV has been utilized in several outbreaks, including an ongoing one in the Democratic Republic of Congo...
WHO worries Merck's Ebola vaccine will run short: report fiercepharma
December 12, 2018
Nearly five months into an Ebola outbreak in the Democratic Republic of Congo, the disease is spreading closer to urban population centers...
Merck gets FDA okay for Keytruda as liver cancer therapy pharmaphorum
December 12, 2018
Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its rivalry with Bristol-Myers Squibb.....
J&J, Merck chip in for $100M U.K. vaccine center fiercepharma
December 11, 2018
To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. government, with help from academic institutions and the pharma industry...
Merck partners with Cyclica for AI-based screening of drug targets pharmaceutical-technology
December 11, 2018
Merck has signed an agreement to licence Canadian Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its research efforts......
Roche’s Tecentriq wins key lung cancer approval. Its prize? A showdown with formidable Merck fiercepharma
December 10, 2018
Merck’s Keytruda finally has some immuno-oncology competition in the previously untreated non-small cell lung cancer market, courtesy of Roche and its freshly minted Tecentriq-Avastin combo.
J&J, Merck chip in for $100M U.K. vaccine center fiercepharma
December 06, 2018
To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. governmen...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page